GALECTIN THERAPEUTICS INC (NASDAQ:GALT) filed a Form 8-K with the Securities and Exchange Commission on January 12, 2026, disclosing a material event.
GALECTIN THERAPEUTICS INC's stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.